Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results this Thursday afternoon. Here’s what investors should know.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Today Earnings: Johnson & Johnson, Morgan Stanley, BlackRock, PNC Financial Services, Conagra, Cintas, United Airlines, Bank of New York Mellon, Elevance Health, J.B. Hunt, ASML Economic data: Producer-price index data for June, Empire State manufacturing survey, EIA weekly petroleum status report, Fed beige book.
Intuitive Surgical's stock has fallen sharply in 2026, but that is more a function of investor sentiment than of the company.
Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.
Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.
Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.
This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
Intuitive Surgical (NASDAQ:ISRG) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ... Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
Intuitive Surgical stock has returned 28.4% over the past five years, yet its current checks point to a company that is not clearly cheap, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model sitting close to the market price while earnings based multiples lean expensive. Over five years, a 28.4% share price gain suggests Intuitive Surgical has rewarded patient holders, even though shorter term returns have been weaker. Growth expectations tied to expanding robotic...
Intuitive Surgical (ISRG) is in focus after voluntarily recalling certain Da Vinci surgical system components tied to a potential E-brake pin issue. This development is prompting fresh attention on product risk and how it might factor into the stock. See our latest analysis for Intuitive Surgical. Against this backdrop, Intuitive Surgical’s short term share price momentum has softened, with the stock down 4.5% over the past week and 9.7% over the past 90 days. However, the 3 year total...
Intuitive Surgical, Inc. (ISRG) closed at $406.78 in the latest trading session, marking a -1.16% move from the prior day.
ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.
Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the 10 Best AI Stocks to Watch in July. On July 6, Evercore ISI lowered its target price for Intuitive Surgical Inc. (NASDAQ:ISRG) to $430 from $480 and kept an In Line rating on the stock. The firm’s Q2 preview for MedTech, Life Sciences Tools, and Diagnostics shows […]
The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.
The options market has priced a sizable range of outcomes for the surgical robotics leader, and if you hold the shares, you are already carrying that full exposure.
Pre-Market Stock Futures: Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up just modestly higher at 25,870, up 0.20%. The S&P 500 also rallied in the afternoon, erasing a big deficit, to finish the session ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, T
If you hold shares in this surgical robotics leader, you are already carrying a sizable two-sided risk, whether you trade options or not.
Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.
ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.
Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.
The company has the elements that make a fantastic long-term investment.
While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Piper Sandler Companies stock has delivered a strong 5 year return, yet with the recent pullback and a mixed valuation score, the current share price around US$71.09 looks less like a straightforward bargain and more like a test of how much investors are willing to pay for its track record. Over the past 5 years the stock has returned 165.8%, which sets a high bar for future returns to justify the current valuation. Positive sentiment around Piper Sandler's research and advisory work, such...
Intuitive Surgical (NasdaqGS:ISRG) reported strong quarterly results, supported by solid procedure volumes and rapid adoption of its new da Vinci 5 system. Management issued softer guidance for future procedure growth, citing competitive pressures and increased regulatory scrutiny. The company was recently added to the Russell 1000 Dynamic Index and removed from the Russell Top 50 Index, altering its index exposure. Intuitive Surgical focuses on robotic assisted surgery, with its da Vinci...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.
Intuitive Surgical has faced margin pressure before and bounced back.
Intuitive Surgical is approaching a pivotal earnings update as strong forecasts square off against a stock that has lost its footing.